About
Igenica is a biopharmaceutical company that discovers and develops antibodies and antibody-drug conjugates (ADCs) for cancer treatment using patient-based discovery approaches and integrated platforms to identify novel oncology targets.
Explore Igenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.